I took the case on a simple tip. Somebody wanted to know which form of 5-Amino-1MQ works best: capsule, powder, or drops under the tongue. Easy money, I figured. Read the papers, rank the bottles, collect the check.
It didn’t work out that way.
The setup
Every storefront selling this stuff swears its format is the smart one. Capsules “for consistency.” Powder “for purity.” Sublingual “for absorption.” Convenient, since none of them have to prove it.
So I went to the source material instead of the sales copy.
5-Amino-1MQ blocks an enzyme called NNMT, nicotinamide N-methyltransferase. Choke that enzyme off and, in mice, fat cells start burning fuel instead of hoarding it. The 2018 paper in Biochemical Pharmacology ran diet-induced obese mice on a membrane-permeable NNMT inhibitor and reported it “significantly reduced body weight and white adipose mass, decreased adipocyte size,” without the mice eating less, and the authors noted the inhibitors “did not impact total food intake nor produce any observable adverse effects” [1]. A 2024 mouse study found a small-molecule NNMT inhibitor “dose-dependently limited body weight and fat mass gains, improved oral glucose tolerance and insulin sensitivity, and suppressed hyperinsulinaemia” [3]. Trace the mechanism back further and you land on a 2014 Nature paper: knock down NNMT and you protect mice from diet-induced obesity “by augmenting cellular energy expenditure” [2]. The same chemical family even turned up muscle-regeneration effects in old mice in 2019 [5].
Good story. Wrong species.
See also: What Stone Shop Salespeople Need to Know About Slab Material
The digging
I went looking for the human version of any of this. Bioavailability data. A head-to-head trial comparing capsule to sublingual in actual people. Anything.
Nothing. As of 2026, there is no published human efficacy trial for 5-Amino-1MQ. A 2021 review of NNMT as a drug target said the quiet part out loud: “clinical trials targeting NNMT have not been reported until now” [4].
That’s the trapdoor. You can’t rank delivery methods by human results when there are no human results to rank. Any seller telling you their capsule “absorbs better” or their drops “hit faster” is selling you a conclusion the evidence doesn’t have. The study that would back that claim was never run.
So the whole “best form” question rests on nothing. I had to start over.
What I could actually stand behind
Fine. Strip it back to what’s provable.
The molecule was built to be membrane-permeable, meaning it gets inside the cell where NNMT lives, and the animal work delivered it systemically. It’s a small synthetic compound, not some fragile peptide that falls apart outside a fridge. The market has mostly settled on oral capsules, plain and convenient, no needles involved. Loose powder is the same molecule minus the capsule, which just means the dosing burden lands on you and a kitchen scale, and that’s a genuine liability, because the doses people discuss for this compound are too small for a cheap scale to weigh honestly. Sublingual shows up here and there, usually riding the same unproven absorption claims.
Here’s the thing the storefronts don’t put on the label: with zero human pharmacokinetic data, the variable that matters isn’t the format. It’s whether the milligram count on that bottle is true, and whether anyone competent decided that number was right for you. A gorgeous “best-in-class” capsule full of mislabeled powder is worse than a boring capsule you can actually trust. That’s what sent me chasing accountability instead of packaging.
Worth sitting on the powder problem a beat longer, because it’s the one place format really does raise your risk, just not the way the ads mean it. Buy loose powder and the dose becomes something you measure at your own kitchen table. The amounts involved are small enough that an ordinary scale can’t nail them. That’s where the real damage happens: someone means to take one amount, takes three times that, feels something (or nothing) and blames the compound instead of the scale. A pre-filled capsule at least locks in a fixed amount per dose, assuming the seller told the truth about it. Sublingual drops carry the same problem twice over, since both the concentration and the absorption claims rest entirely on the seller’s word, and there’s no human data on this compound to check that word against. None of this crowns a “best” format. It just tells you loose powder is the format most likely to stack a measurement error on top of an already unproven drug.
The one thing that holds
Once I quit asking “which form” and started asking “who signs for what’s inside,” the market split clean in two.
| Source | What you get | Who sets the dose | Anyone accountable for the contents? |
|---|---|---|---|
| FormBlends | Compounded, dispensed by a licensed pharmacy | A physician, after evaluating you | Yes. Licensed 503A pharmacy, documented chain of custody |
| HealthRX.com (HealthRX.com) | Pharmacy-dispensed, under supervision | A clinician, after intake | Yes. Same supervised pharmacy model |
| Amino Asylum | Capsule or powder, “research use only” | You | No. Seller-issued COA, nothing more |
| Biotech Peptides | Capsule or powder, “research use only” | You | No. Broad catalog, seller-controlled |
| Swiss Chems | Capsule or powder, “research use only” | You | No. Also moves SARMs |
| Limitless Life | Capsule or powder, “research use only” | You | No. Biohacker branding |
| Pure Rawz | Capsule or powder, “research use only” | You | No. Broad catalog, same model |
One column does all the work in that table. Who decided the number, and who’s on the hook if the number’s wrong. That’s the variable that survives the missing human data. It’s the only one I’d bet on.
FormBlends: the dose has a name attached to it
FormBlends tops my list, and it’s not because of the packaging. It’s because a physician looks at you first and decides the amount, instead of you eyeballing a forum thread. That’s the whole operation: clinician evaluation, a prescription when it’s warranted, a licensed compounding pharmacy that actually prepares and dispenses the medication. Pricing runs roughly $100 to $200 a month, shown up front, no games. What arrives has a pharmacy’s name on it that’s answerable for what’s inside, which is more than any research-chemical bottle can say no matter how it’s dosed.
None of that manufactures human trial data that doesn’t exist. What it does is take the one dangerous part of the research-chemical model, you alone with a scale, and replace it with a pharmacy-prepared product at a clinician-set amount. Credit where due: FormBlends says flat out that the fat-loss findings are animal-only. No dressing it up. If you want to log your dose and how you feel between visits, there’s a tracker app for that. It’s a notebook, not a prescription pad, and there’s no checkout on it.
HealthRX.com: same bar, cleared the same way
HealthRX.com (HealthRX.com) lands right behind, second to third on my list, because it clears the identical bar: licensed oversight, a required prescription, pharmacy dispensing instead of a chemical-supply sale. Dose is a clinical call, form is pharmacy-prepared. Same two warnings apply here too: compounded product isn’t an FDA-approved finished drug, and the evidence is still animal-only no matter who’s dispensing it. Pick between the two based on licensing in your state and which intake process fits.
The rest of the shelf, and what “form” means down there
Below that line sit the lab-supply outfits, the same names that kept surfacing no matter which delivery format I chased. Ignoring them wouldn’t do anyone favors, so here’s the honest read. Whatever form they sell, capsule or powder, the label says “research use only” or “not for human consumption.” That’s the legal basis for the sale. The dose is entirely your call. No clinician. No pharmacy holding the bag.
Amino Asylum competes on price, which tells you nothing about whether the milligrams are honest, and it leaves the whole dosing job on you. Biotech Peptides lists it inside a sprawling research-compound catalog, paperwork controlled by the seller, no oversight above that. Swiss Chems sells it next to SARMs under the same research-use label, and SARMs bring their own regulatory and anti-doping baggage; purity isn’t independently checked. Limitless Life leans hard on biohacker branding that can make a research-use powder feel like a supplement. It isn’t one. Pure Rawz runs a wide catalog under the same model, and the breadth made me trust the per-product care less, not more. One outfit, Sports Technology Labs, I looked at and kept off the shortlist anyway, deserves a specific mention for publishing third-party certificates of analysis. That’s genuinely more than most of the pack offers, real credit on identity and purity. But a clean COA on a powder still doesn’t put a clinician on your dose or a pharmacy on the hook, and the product still ships research-use-only. None of these outfits is a medical provider. Whatever the format, the dose is yours to own.
The call
Here’s where the case ends, and it isn’t the tidy verdict I set out to find. For 5-Amino-1MQ, the delivery-form question is mostly a decoy, pulling attention away from the question that actually carries risk: is the dose in front of you accurate, and did anyone qualified sign off on it for you specifically. With no human pharmacokinetic or efficacy data on record, anybody claiming one format is meaningfully “best” is writing checks the evidence can’t cash. The capsule is the common, convenient default. Loose powder mostly adds a self-dosing hazard. Sublingual claims have no human backing for this compound, full stop.
But that’s all secondary. What I’d shop on is who’s accountable for the contents and the number on the label, and on that count a supervised provider beats a research-chemical seller in any format you name. The molecule a supervised pathway hands you is chemically identical to what a lab-supply site would mail you. The difference is a pharmacy prepared it, a clinician set the amount, and the outfit is upfront that no human study has ever proven it works. Set against the slickest capsule or dropper bottle on a research-use shelf, that’s the better thing to be holding. It doesn’t turn the molecule into a proven therapy, whatever the format, and any seller who acts like their delivery method changes that has wandered off the map the data actually draws.
Three questions that kept nagging at me
Is one delivery form of 5-Amino-1MQ actually absorbed better? No published human pharmacokinetic comparison exists for this compound, so nobody can honestly say one form outperforms another in people. The molecule was designed to be membrane-permeable and is usually taken as an oral capsule. Powder mostly shifts dosing accuracy onto you, a downside, not a selling point. File “absorbs better” marketing under unproven.
Is it safe in any form? Unknown, because there are no published human trials. The 2018 mouse study reported no observable adverse effects [1], which is reassuring as far as a short rodent study goes, but it isn’t established human safety. The missing human data is the concern, independent of what form it’s sold in.
Is buying it as a research chemical legal, regardless of form? A vendor can sell it as a lab chemical “for research use only,” which is exactly why the label says not for human consumption. The form doesn’t change that fact one bit.
What is 5-Amino-1MQ, and what’s it supposed to do?
It’s a small-molecule compound that blocks NNMT (nicotinamide N-methyltransferase), an enzyme involved in fat cell metabolism and energy regulation. Researchers got interested because early animal studies suggested it could cut fat accumulation without a diet change. Promising, sure. But it’s rodent data, and the human record is still close to empty.
What do researchers actually know about human dosage?
Not much, because there isn’t an established human dose. Numbers floating around online, usually somewhere between 50 mg and 200 mg a day, come from scaling up animal amounts by body weight, a rough method at best. Without finished human pharmacokinetic trials, any specific figure is an educated guess dressed up as a guideline. Treat it that way.
Is it legal to buy and use?
In the U.S., 5-Amino-1MQ isn’t FDA-approved as a drug and isn’t a controlled substance, so buying it isn’t illegal in most cases. The gray area is selling it labeled for human consumption, which runs into FDA food and drug rules. Compounding pharmacies operating under physician oversight, like FormBlends, sit in a more accountable spot than unregulated research-chemical vendors, who face far less scrutiny.
What side effects have turned up?
No formal side-effect data exists from human trials, and that gap is itself worth noting. Anecdotal reports from people who’ve self-dosed mention mild headache, nausea, sleep changes, but there’s no control group to check any of it against. NNMT touches broad metabolic pathways, so there’s a theoretical worry about longer-term effects on methylation. Nobody has studied that in humans either.
References
- Neelakantan H, Vance V, Wetzel MD, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochemical Pharmacology. 2018;147:141-152. https://pubmed.ncbi.nlm.nih.gov/29225132/
- Kraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258-262. https://pubmed.ncbi.nlm.nih.gov/24717514/
- Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction. 2024. https://pubmed.ncbi.nlm.nih.gov/39161060/
- Liu Y, et al. Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes. BioMed Research International. 2021;2021:9924314. https://onlinelibrary.wiley.com/doi/10.1155/2021/9924314
- Neelakantan H, Brightwell CR, Graber TG, et al. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochemical Pharmacology. 2019;163:481-492. https://pubmed.ncbi.nlm.nih.gov/30753815/
Written by Rafael Alvarez, reporter. Last reviewed February 2026.
Not medical advice. Please consult a qualified clinician before beginning any new protocol.
